People with type 2 diabetes who stop taking GLP-1 drugs such as Ozempic, Wegovy and Mounjaro may face twice the risk of heart attack, stroke or death compared…
People with type 2 diabetes who stop taking GLP-1 drugs such as Ozempic, Wegovy and Mounjaro may face twice the risk of heart attack, stroke or death compared with those who continue treatment, new research suggests
Source disclosure
This is a source-linked briefing. Read the original report from Irish Mirror .